Overview
- 5 inspections across 3 sites are on record.
- 17 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2019-06-25.
At a glance
Inspections
5
Sites
3
Observations
17
Career since
Apr 2019
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Infusion Options Inc. | 25 Jun 2019 | Human Drugs | On file |
| Infusion Options, Inc. | 25 Jun 2019 | Human Drugs | View 483 → |
| Infusion Options, Inc. | 20 Jun 2019 | Human Drugs | |
| Infusion Options, Inc. | 16 May 2019 | Human Drugs | |
| Heartland New York, Inc. | 11 Apr 2019 | Foods & Cosmetics | View 483 → |
Sites inspected
Infusion Options Inc.Brooklyn, United States1 insp.
Infusion Options, Inc.Brooklyn, United States3 insp.
Heartland New York, Inc.Flushing, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Full investigator report
Get the verbatim findings behind Kevin J Flessa's 17 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site